EUVIMEDEUVIMED entdecken
Crossref

Species Differences in Carboxylesterases Among Humans, Cynomolgus Monkeys, and Mice in the Hydrolysis of Atorvastatin Derivatives

Masato Takahashi iD, Sachiko Sakai, Kohei Takahashi, Masakiyo Hosokawa

Biopharmaceutics & Drug Disposition · 2025

DOI: 10.1002/bdd.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, 2025. Verfasst von Masato Takahashi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Chiba Institute of Science, Chiba, Japan. Hauptthemen laut MEDLINE: Atorvastatin, Carboxylic Ester Hydrolases, Carboxylesterase, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Chiba Institute of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonclinical trials are crucial for assessing pharmaceutical efficacy and safety prior to clinical trials. However, disparities in drug metabolism between humans and animals complicate extrapolating animal data to humans. Variability in drug‐metabolizing enzymes, such as carboxylesterases (CESs), contributes to differences in drug kinetics. This study aimed to explore species disparities in CES substrate specificity among humans (hCES1), mice (mCES1), and cynomolgus monkeys (mfCES1) using diverse atorvastatin ester derivatives. This study measured hydrolysis rates of 30 atorvastatin derivatives. Metabolites were identified via HPLC with an internal standard, measuring rates per unit time and enzyme amount. Enzyme metabolic activity was compared using hydrolysis rates. The structure of the alkoxy group resulted in differences ranging from approximately half to 8.97‐fold between hCES1 and mCES1 and differences ranging from similar to 15.82‐fold between hCES1 and mfCES1. Caution is warranted when extrapolating animal data to humans, especially for esters with diverse structures. Our focus on the alkoxy group structure highlights its impact on hydrolysis rates. Further investigation into species differences among CES enzymes is essential for accurate translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtorvastatinCarboxylic Ester HydrolasesCarboxylesteraseHydroxymethylglutaryl-CoA Reductase InhibitorsAnimalsMacaca fascicularisHydrolysisMiceHumansSpecies SpecificitySubstrate SpecificityMale

Stichwörter der Autor:innen

atorvastatincarboxylesterasemetabolismprodrugspecies difference

Substanzen

AtorvastatinCarboxylic Ester HydrolasesCarboxylesteraseHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Chiba Institute of Science, Chiba, Japan.

ORCID-Profile: Masato Takahashi

Förderung

  • Chiba Institute of Science

Zitieren

APA

Takahashi, M., Sakai, S., Takahashi, K., & Hosokawa, M. (2025). Species Differences in Carboxylesterases Among Humans, Cynomolgus Monkeys, and Mice in the Hydrolysis of Atorvastatin Derivatives. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.70003

Vancouver

Takahashi M, Sakai S, Takahashi K, Hosokawa M. Species Differences in Carboxylesterases Among Humans, Cynomolgus Monkeys, and Mice in the Hydrolysis of Atorvastatin Derivatives. Biopharmaceutics & Drug Disposition. 2025. doi:10.1002/bdd.70003

BibTeX
@article{Takahashi2025,
  author = {Takahashi, Masato and Sakai, Sachiko and Takahashi, Kohei and Hosokawa, Masakiyo},
  title = {Species Differences in Carboxylesterases Among Humans, Cynomolgus Monkeys, and Mice in the Hydrolysis of Atorvastatin Derivatives},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2025},
  doi = {10.1002/bdd.70003}
}
Kostenlos starten →